Biogen Inc. (LON:0R1B)
London
· Delayed Price · Currency is GBP · Price in USD 120.67
+2.35 (1.99%)
At close: Apr 29, 2025
Biogen Employees
Biogen had 7,605 employees as of December 31, 2024. The number of employees increased by 35 or 0.46% compared to the previous year.
Employees
7,605
Change (1Y)
35
Growth (1Y)
0.46%
Revenue / Employee
999.05K GBP
Profits / Employee
150.55K GBP
Market Cap
13.29B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| HUTCHMED (China) | 1,811 |
| Genus | 3,500 |
Biogen News
- 6 days ago - Biogen: Is This A Value Trap, Or Is The Great Turnaround Imminent? - Seeking Alpha
- 15 days ago - Europe Approves Eisai-Biogen's Alzheimer's Drug 'Under Strict Conditions' After Initial Negative Opinion - Benzinga
- 16 days ago - Leqembi®∇ (lecanemab) is the First Medicine that Slows Progression of Early Alzheimer's Disease to be Authorized in the European Union - GlobeNewsWire
- 16 days ago - Biogen/ Eisai win EU approval for Alzheimer’s therapy - Seeking Alpha
- 16 days ago - EU authorizes Eisai-Biogen's drug for treatment of early Alzheimer's disease - Reuters
- 22 days ago - Sage Therapeutics: Biogen's $7.22/Share Bid Might Say More Than The Price Tag - Seeking Alpha
- 27 days ago - Vertex, Alnylam Best Positioned As Biopharma Braces For Tariff Impact, Goldman Sachs Flags Regeneron, Biogen Risks - Benzinga
- 27 days ago - Biogen downgraded to Hold at Argus on profit decline expectations - Seeking Alpha